Search Results for: Avandia

Featured Stories
DeflateGate’s Effects Impact Legal Gambling and the Economy

DeflateGate’s Effects Impact Legal Gambling and the Economy

The NFL has initiated a probe into the New England Patriots following allegations that the team intentionally used overly deflated footballs.

Read More

FDA Questions Device Makers about Duodenoscope Cleaning Procedures

Following Deadly Outbreaks, FDA Questions Device Makers about Duodenoscope Cleaning Procedures

In light of a recent outbreak linked to contaminated duodenoscopes, the U.S. Food and Drug Administration (FDA) is questioning manufacturers about their methods for cleaning the devices, the New York Times reports. The specialized scopes, which have been linked to several outbreaks in recent years, most recently infected seven patients ...

Read More

Older Patients Face Heart Attack Risk Following Surgery

Older Hip Implant, Knee Replacement Patients Face Heart Attack Risk Following Surgery

An emerging report reveals that older hip implant and knee replacement patients face increased heart attack risks following surgery. The risk for acute myocardial infarction (AMI) was seen in the first two weeks after these surgical procedures.

Read More

New York City Council Calls for Zadroga Act to be Renewed

New York City Council Calls for Zadroga Act to be Renewed

New York City Council members are calling for the Zadroga Act, which provides compensation and medical treatment to 9/11 victims, to be renewed. According to press release issued Jan. 7, a resolution was introduced by Council Member Margaret Chin, Council Speaker Melissa Mark-Viverito and Council Members Paul Vallone and I. ...

Read More

Pradaxa not Fit for a Dog, Family of Alleged Pradaxa Bleeding Victim Claims

The family of a Texas woman who died just months before her 60th wedding anniversary believes she would be alive today were it not for Pradaxa (dabigatran). According to a report from the Houston Press, Pradaxa patient Loraine Franklin fell and hit her head last December, resulting in an intracranial ...

Read More

Study Finds Plavix May Only Benefit Smokers

An emerging study finds that blood thinner Plavix may only benefit smokers. Plavix (clopidogrel) is prescribed for the prevention of blood clots and heart attacks, and has been linked to serious side effects, including the heart attacks and strokes it is supposed to prevent, gastrointestinal and cerebral bleeding, bleeding ulcers, ...

Read More

First DePuy ASR Hip Implant Lawsuits Head to Trial in December, January

The first trials involving lawsuits filed against DePuy Orthopaedics by recipients of its recalled ASR Hip Implants will begin later this year, and early next year. The first is slated to start on December 3, 2012 in state court in Las Vegas, Nevada. A second DePuy ASR hip implant lawsuit ...

Read More

Conspiracy Claims in Talcum Powder Case Survive Motion to Dismiss

Conspiracy Claims in Talcum Powder Case Survive Motion to Dismiss

E. District of Missouri denied motion to dismiss conspiracy claims. Lawsuit alleges the defendants conspired to misrepresent true dangers with use of talcum powder.

Read More

Former Executives Accuse Health Technology Firm of Fraud

Former Executives Accuse Health Technology Firm of Fraud

Former NantHealth executives claim that the company made fraudulent claims about the reliability of its system, which links patient information gathered by the devices.

Read More

European Regulators Urged to Pull Avandia

We recently wrote that emerging research has added to the growing body of evidence linking the diabetes drug < "http://www.yourlawyer.com/topics/overview/avandia">Avandia (generic: rosiglitazone) to increased adverse health risks. That issue is cardiac, according to the LA Times. Now, the Wall Street … Continue reading

Posted in Avandia, Pharmaceuticals |

Study Sees Same Heart Risks Seen With Actos, Avandia

New research has added to the growing body of evidence linking < "http://www.yourlawyer.com/topics/overview/avandia">Avandia and < "http://www.yourlawyer.com/topics/overview/actos">Actos to increased adverse health risks. This time, the issue is cardiac, said the LA Times. Avandia has long been surrounded with debate concerning cardiovascular … Continue reading

Posted in Avandia, Pharmaceuticals |

Glaxo Under Fire for Avandia Memo

The New York Times is reporting that the credibility of an < "http://www.yourlawyer.com/topics/overview/avandia">Avandia memo from GlaxoSmithKline detailing last month’s advisory panel meeting on the controversial diabetes drug is being attacked. A federal official and some members of that same advisory … Continue reading

Posted in Avandia, Pharmaceuticals |

Questions Over Avandia Disclosures Prompt FDA Probe

< "http://www.yourlawyer.com/topics/overview/avandia">Avandia may be about to cause more trouble for GlaxoSmithKline. According to a report in TIME Magazine, the US Food & Drug Administration (FDA) is trying to determine if Glaxo broke the law when it didn’t disclose data on … Continue reading

Posted in Avandia, Pharmaceuticals |

Another Study Sees Avandia, Actos Fracture Risk

Another study has added to the growing body of evidence linking < "http://www.yourlawyer.com/topics/overview/avandia">Avandia and < "http://www.yourlawyer.com/topics/overview/actos">Actos to an increased risk of fractures. This latest research, which appears in the Journal of Clinical Endocrinology & Metabolism, found that the drugs increased … Continue reading

Posted in Avandia, Pharmaceuticals |

FDA Refers Avandia Panel Conflict Question to HHS

Federal drug regulators have referred a potential conflict-of-interest problem on an < "http://www.yourlawyer.com/topics/overview/avandia">Avandia advisory panel to the inspector general’s office at the Department of Health and Human Services’ (HHS). Earlier this month, the sharply divided Food & Drug Administration (FDA) … Continue reading

Posted in Pharmaceuticals |

Avandia Decision Coming in September, European Regulators Say

European regulators will decide by September if < "http://www.yourlawyer.com/topics/overview/avandia">Avandia will be allowed to stay on the market there. The European Medicines Agency (EMEA) said yesterday that it is still reviewing GlaxoSmithKline’s controversial diabetes drug, which has been linked to an … Continue reading

Posted in Avandia, Pharmaceuticals |

FDA Halts Avandia Study Enrollment

US health regulators have ordered GlaxoSmithKline to stop recruiting patients for an < "http://www.yourlawyer.com/topics/overview/avandia">Avandia trail. The trial, called TIDE (Thiazolidinedione Intervention With Vitamin D Evaluation), was designed to compare the long-term effects of Avandia with another diabetes drug called Actos. … Continue reading

Posted in Avandia, Pharmaceuticals |

FDA Advisor Who Voted in Favor of Avandia Had Ties to Glaxo

One of the members of a government advisory panel who voted to back < "http://www.yourlawyer.com/topics/overview/avandia">Avandia last week was on GlaxoSmithKline’s payroll. According to The Wall Street Journal, Endocrinologist David Capuzzi of Philadelphia is a paid speaker for the drug maker. … Continue reading

Posted in Avandia, Pharmaceuticals |

Avandia Should Stay on Market, But Restrict Sales, FDA Advisory Panel Says

While < "http://www.yourlawyer.com/topics/overview/avandia">Avandia poses “significant safety concerns,” a sharply divided Food & Drug Administration (FDA) panel voted that the controversial diabetes drug should be allowed to stay on the market. However, the panel of outside experts also said sales of … Continue reading

Posted in Avandia, Pharmaceuticals |

© 2005-2020 Parker Waichman LLP ®. All Rights Reserved.